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α-HelixIn the present workwe have analyzed the effect of StAsp-PSI (plant-speciﬁc insert of potato aspartic protease) on
the structural and thermotropic properties of the major phospholipid types of bacterial and animal cells. Results
obtained suggest that StAsp-PSI induces a destabilization of the membrane bilayers, depending on the time of
interaction between the protein and the bilayers, rather than on its concentration. This temporal delay would
be consistent with a lateral diffusion of StAsp-PSI monomers to assemble into aggregates to form pores. Like
with the results previously reported for the StAsp-PSI circular dichroism, data obtained here from IR spectroscopy
show that there are slight changes in the StAsp-PSI secondary structure in the presence of lipid membranes;
suggesting that these changes could be related with the StAsp-PSI self-association. Results obtained from
steady-stateﬂuorescence anisotropy and differential scanning calorimetry assays suggest that StAsp-PSI interacts
with both uncharged and negatively charged phospholipids, modulates the phase polymorphic behavior of
model membranes and partitions and buries differentially in the membrane depending on the presence of
negatively charged phospholipids.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The clinical incidence ofmulti drug-resistantmicrobes has increased
dramatically in recent decades [1,2]. Membrane-permeabilizing antimi-
crobial peptides (AMPs) have long been discussed as a possible novel
class of antibiotics that could be used against multi drug-resistant
microbes, but a poor understanding of the fundamental principles of
AMP action has slowed the development of AMPs into clinical useful
drugs [1].
AMPs are an integral part of the innate immune system of higher
organisms [1,3–6]. These host defense proteins and peptides possess a
wide spectrum of antimicrobial activity against eubacteria, fungi, virus-
es and eukaryotic parasites [2,7,8]. AMPs are attractive as therapeutic
tools because they act without high speciﬁcity toward a protein target,
which reduces the likelihood of induced resistance [9–11]. Therefore,ins; DMPC, 1,2-dimyristoylphos-
ol; DMPS, 1,2-dimyristoylphos-
ifferential scanning calorimetry;
ylglycerol; IR, infrared spectros-
esicles; PSI, plant-speciﬁc insert;
ylammoniumphenyl)-6-phenyl-
del Plata 7600, Argentina. Tel.:
.
ights reserved.understanding themechanism of membrane permeabilization is crucial
for the development of AMPs into useful antimicrobial agents [1].
Aspartic proteases (APs) (EC 3.4.23) are a class of widely distributed
proteases present in animals, microbes, viruses and plants [12,13].
Biological functions of plant APs have not yet been characterized to
the extent of their mammalian, microbial or viral counterparts [12–15].
Plant AP sequences predict preproproteins similar to the animal and
fungal aspartic proteases, with a signal peptide and a proregion at the
amino-terminus of the mature protein. Plant AP genes, with the excep-
tion of nucellin, a barley AP [16] and AP encoded by the cdr-1 gene
from Arabidopsis [17], have an extra region of approximately 100 amino
acids known as “plant speciﬁc insert” (PSI). This sequence has structural
similarity with the precursor of mammalian saposins, lysosomal
sphingolipid-activating proteins (SAPLIPs) [18,19].
Previously, we have reported the cloned, heterologous expression
and puriﬁcation of the PSI domain from a Solanum tuberosum aspartic
protease (StAsp, accession number AY672651) named StAsp-PSI [20].
StAsp-PSI has high structural similarity with two lipid interacting
proteins, saposin-like proteins (SAPLIPs), with antimicrobial activity
NK-lysin and granulysin [20,21], both proteins classiﬁed as AMPs in
the database available online at: http://aps.unmc.edu/AP/main.php
[22]. Like these SAPLIPs, the StAsp-PSI domain is able to interact with
cell plasma membranes, increasing the cell permeability and ﬁnally,
producing cell death [20,23]. Additionally, we have demonstrated in
previous reports that the cytotoxic activity of StAPs and StAsp-PSI is
selective [20,24]. Whereas these proteins are toxic to plant and human
pathogenic microorganisms i.e., fungi, oomycetes, Gram− and Gram +
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human red blood cells and plant cells [20,23–28]. Results obtained
from vesicle leakage assays, circular dichroism spectroscopic mea-
surements and analysis by size exclusion chromatography followed
by electrophoresis showed that StAsp-PSI is a potent inducer of the
leakage of LUVs composed of anionic phospholipids, especially those
containing phosphatidylglycerol. Signiﬁcantly, a hydrophobic environ-
ment is necessary for StAsp-PSI oligomerization and both StAsp-PSI
disulﬁde bonds and negatively charged phospholipids are required to
produce membrane destabilization which afterwards would induce
cell death in tumors andmicroorganism cell targets. Moreover, the pres-
ence of cholesterol in themembrane strongly diminishes the capacity of
StAsp-PSI to produce leakage, suggesting that the lack of hemolytic and
cytotoxic activities on human lymphocytes of StAsp-PSI/StAPs may be
partly due to the presence of cholesterol in these types of cellmembranes
[29].
In order to deepen the mechanism of interaction between StAsp-PSI
and phospholipidmembranes, we have analyzed the structural changes
in protein–membrane bilayer structures at the molecular level during
their interaction. This study was performed using biophysical methods,
namely measurements of leakage of a ﬂuorescent probe, infrared spec-
troscopy (IR), steady-state ﬂuorescence anisotropy and differential
scanning calorimetry (DSC). The results obtained indicate that StAsp-
PSI interacts with both uncharged and negatively charged phospho-
lipids,modulates the phase polymorphic behavior ofmodelmembranes
and partitions and buries differentially in the membrane depending on
the presence of negatively charged phospholipids.
2. Materials and methods
2.1. Protein expression and puriﬁcation
Recombinant StAsp-PSI was overexpressed in Escherichia coli M15
and puriﬁed as described previously [20]. Protein concentration was
measured by the bicinchoninic acid method [30], using BSA as the
standard.
2.2. Materials and reagents
Egg L-α-phosphatidylcholine (EPC), egg L-α-phosphatidylglyce-
rol (EPG), 1,2-dimyristoylphosphatidylserine (DMPS), 1,2-dimyristoyl-
phosphatidylcholine (DMPC), and 1,2-dimyristoylphosphatidylglycerol
(DMPG) were obtained from Avanti Polar Lipids (Alabaster, AL,
USA). Fluorescein isothiocyanate labeled dextran FD-70 and Triton
X-100 were obtained from Sigma-Aldrich (Madrid, ES). 1,6-diphenyl-
1,3,5-hexatriene (DPH), and 1-(4-trimethylammoniumphenyl)-6-
phenyl-1,3,5-hexatriene (TMA-DPH) were obtained from Molecular
Probes (Eugene, OR). All other chemicals were commercial samples of
the highest purity available (Sigma-Aldrich, Madrid, ES). Water was
deionized, twice-distilled and passed through a Milli-Q equipment
(Millipore Ibérica, Madrid, ES) to a resistivity higher than 18 MΩ cm.
2.3. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform–
methanol (2:1 vol/vol) were placed in a test tube, the solvents were
removed by evaporation under a stream of O2-free nitrogen, and ﬁnally,
traces of solvents were eliminated under vacuum in the dark for more
than 3 h. The lipid ﬁlms were resuspended in an appropriate buffer
and incubated either at 25 °C or 10 °C above the phase transition
temperature (Tm) with intermittent vortexing for 30 min to hydrate
the samples and obtain multilamellar vesicles (MLVs). The samples
were frozen and thawed ﬁve times to ensure complete homogenization
and maximization of peptide/lipid contacts with occasional vortexing.
Large unilamellar vesicles (LUVs) with a mean diameter of 0.2 μm were
prepared from MLVs by the extrusion method [31] using polycarbonateﬁlters with a pore size of 0.2 μm (Nucleopore Corp., Cambridge, CA,
USA). For infrared spectroscopy, aliquots containing the appropriate
amount of lipid in chloroform/methanol (2:1 v/v)were dried by evapora-
tion under a stream of O2-free nitrogen and traces of solvents were
eliminated under vacuum in the dark for more than 3. 300 μg of StAsp-
PSI was placed in a test tube containing the dried lipid and then lyophi-
lized (lipid/protein ratio 50:1). The samples were hydrated in 200 μl
D2O, mixed at 4 °C overnight, and lyophilized again. The samples were
rehydrated in 30 μl D2O and kept at 4 °C overnight to allow StAsp-PSI
refolding. Finally, the suspensions were gently agitated at room tempera-
ture for 30 min to obtain MLVs and incubated at 40 °C for 1 h with occa-
sional vortexing.
2.4. Membrane leakage measurement
For assays of vesicle leakage, LUVs with a mean diameter of 0.2 μm
were prepared as indicated above in buffer containing 10 mM Tris–
HCl, 100 mM NaCl, and 100 mg/ml FD70, pH 7.4. Non-encapsulated
dextran was removed by gel-ﬁltration chromatography using a pump
P-50 (Amersham Pharmacia Biotech AB, Uppsala, Sweden) with a
Sephacryl® 500-HR column eluted with the same buffer described
above, at a ﬂow rate of 3 ml/min. The ﬁnal lipid concentration was
0.075 mM in a 5 mm × 5 mm ﬂuorescence cuvette (ﬁnal volume
of 400 μl), stabilized at 25 °C and under constant stirring. Fluorescence
wasmeasured using a Varian Cary Eclipse spectroﬂuorimeter. One hun-
dred percent release was achieved by adding Triton X-100 to either the
microtiter plate or the cuvette to the ﬁnal concentration of 0.5% (w/w).
Changes in ﬂuorescence intensity were recorded with excitation and
emission wavelengths set at 492 and 517 nm, respectively. Excitation
and emission slits were set at 5 nm. Leakage was quantiﬁed on a per-
centage basis as previously described by Bernabeu et al. and Moreno
et al. [32,33].
2.5. Infrared spectroscopy
Approximately 30 μl of a resuspended sample in D2O was placed
between two CaF2 windows separated by 50-μm thick Teﬂon spacers
in a liquid demountable cell (Harrick, Ossining, NY). The spectra were
obtained in a Bruker IFS55 spectrometer using a deuterated triglycine
sulphate detector. Each spectrum was obtained by collecting 250 inter-
ferograms with a nominal resolution of 2 cm−1, transformed using
triangular apodization and, in order to average background spectra
between sample spectra over the same time period, a sample shuttle
accessory was used to obtain sample and background spectra. The
spectrometer was continuously purged with dry air at a dew point
of −40 °C in order to remove atmospheric water vapor from the
bands of interest. All samples were equilibrated at the lowest tempera-
ture for 20 min before acquisition. An external bath circulator,
connected to the infrared spectrometer, controlled the sample temper-
ature. For temperature studies, samples were scanned using 2 °C inter-
vals and a 2 min delay between each consecutive scan. The data were
analyzed as previously described by Giudici et al. and Guillen et al.
[34,35]. Subtraction of buffer spectra taken at the same temperature as
the samples was performed interactively using either GRAMS/32 or
SpectraCalc (Galactic Industries, Salem, MA) as described previously
by Contreras et al. [36]. Frequencies at the center of gravity, when
necessary, were measured by taking the top 10 points of each speciﬁc
band and ﬁtted to a Gaussian band. Band-narrowing strategies were
applied to resolve the component bands in the Amide I′ region. Second-
derivative spectra were calculated over a 15-data point range. Fourier
self-deconvolution of the subtracted spectra was carried out using a
Lorentzian shape and a triangular apodizationwith a resolution enhance-
ment parameter, K, of 2.2,which is lower than log (signal/noise) and a full
width at half-height of 18 cm−1 [37,38]. These parameters assumed that
the spectra were not overdeconvolved as was evidenced by the absence
of negative side lobes. Protein secondary structure elements were
Fig. 1. Effect of StAsp-PSI on the release of FD70 ﬂuorescent dye from membranes com-
posed of EPC/EPG at a molar ratio of 5:4 and pH 7. The StAsp-PSI concentrations used
were 0 μM (◊), 1.25 μM (■), 2.48 μM (□), 5 μM (●), and 8.26 μM (○). Error bars indicate
standard deviations of the mean of triplicate samples.
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original Amide I′ band after spectral smoothing using the same software
stated above [39]. Brieﬂy, for each component, three parameters were
considered: band position, band height, and bandwidth. The number
and position of component bands were obtained through deconvolution
and in decomposing the Amide I′ band, Gaussian components were
used. The curve-ﬁtting procedure was accomplished in two steps: in the
ﬁrst one, bandpositionwasﬁxed, allowingwidth andheights to approach
ﬁnal values, and in the second one, band positions were left to change.
When necessary, these two steps were repeated. Band decomposition
was performed using SpectraCalc (Galactic Industries, Salem, MA). The
ﬁtting result was evaluated visually by overlapping the reconstituted
overall curve on the original spectrum and by examining the residual
obtained by subtracting the ﬁtting from the original curve. The procedure
gave differences of less than 2% in band areas after the spectra were sub-
mitted to the curve ﬁtting procedure. The frequency positions of the band
centers were independently evaluated by second derivative procedures,
being always very close to the positions found by deconvolution.
2.6. Steady-state ﬂuorescence anisotropy
Aliquots of TMA-DPH or DPH in N,N′-dimethylformamide were
directly added into MLVs formed in 10 mM Tris, 100 mM NaCl,
0.1 mM EDTA, and pH 7.4 to obtain a probe/lipid molar ratio of 1/500.
Samples were incubated for 15 or 60 min when TMA-DPH or DPH was
used, respectively, 10 °C above the gel to liquid crystalline phase transi-
tion temperature Tm of the phospholipidmixture. Afterwards, StAsp-PSI
was added to obtain a lipid/protein molar ratio of 25:1 and incubated at
40 °C for 1 h, with occasional vortexing. All ﬂuorescence studies were
carried using 5 mm × 5 mm quartz cuvettes in a ﬁnal volume of 400 μl
(315 μM lipid concentration). The steady-state ﬂuorescence anisotropy,
brN, was measured with an automated polarization accessory using a
Varian Cary Eclipse ﬂuorescence spectrometer, coupled to a Peltier for
automatic temperature change. Samples were excited at 360 nm (slit
width, 5 nm) and ﬂuorescence emission was recorded at 430 nm (slit
width, 5 nm). The datawere analyzed as previously described byMoreno
et al. [33].
2.7. Differential scanning calorimetry
MLVs were formed as stated above in 50 mM phosphate buffer,
25 mM NaCl, and pH 8. StAsp-PSI was added to obtain a lipid/protein
molar ratio of 25:1. The ﬁnal volume was 1.2 ml (0.5 mM lipid concen-
tration) and incubated at 40 °C for 1 h with occasional vortexing. DSC
experimentswere performed in a VP-DSC differential scanning calorim-
eter (MicroCal LLC, MA) under a constant external pressure of 30 psi in
order to avoid bubble formation, and samples were heated at a constant
scan rate of 60 °C/h. Experimental data were corrected from small mis-
matches between the two cells by subtracting a buffer baseline prior to
data analysis. The excess heat capacity functions were then analyzed by
using Origin 7.0 (MicroCal Software). The thermograms were deﬁned
by the onset and completion temperatures of the transition peaks
obtained from heating scans. In order to avoid artifacts due to the
thermal history of the sample, the ﬁrst scan was never considered;
second and further scans were carried out until a reproducible and
reversible pattern was obtained.
3. Results
3.1. Destabilization of negatively charged membranes
Previously, we showed the ability of StAsp-PSI to induce the release
of trapped small ﬂuorescent dyes (i.e., calcein and carboxyﬂuorescein)
from negatively charged phospholipid bilayer vesicles composed of
EPC/EPG (5:4) [29]. In order to determine the degree of destabilization
of membranes induced by the interaction of StAsp-PSI, we analyzedthe release of encapsulated FD70, a ﬂuorescent probe with an average
molecular weight of 70,000 and a Stokes radius of about 60 Å [40], in
anionic model membranes. As shown in Fig. 1, StAsp-PSI was also able
to induce leakage of ﬂuorophores larger than carboxyﬂuorescein or
calcein. Results obtained show that the initial rate and the maximal
percentage of the FD70 release induced by StAsp-PSI were dose-
dependent (Fig. 1), suggesting that StAsp-PSI can induce a great destabi-
lization of the bilayer membrane, i.e., StAsp-PSI would induce the
formation of pores having at least 60 Å diameter where FD70molecules
can leak out the vesicle. On the other hand, the leakage activity of StAsp-
PSIwas increased by extending the incubation time in the leakage assay,
even at low concentrations (Fig. 1), suggesting a stronger dependence
of the leakage effect on the time of interaction between the protein
with the bilayers than on its concentration.3.2. Secondary structure of StAsp-PSI
The existence of structural changes on StAsp-PSI induced by mem-
brane binding was investigated by analyzing the infrared Amide I′
band located between 1700 and 1600 cm−1 by Fourier transform infra-
red spectroscopy (Fig. 2). The Amide I′ region of the fully hydrated
StAsp-PSI in buffer is shown in Fig. 2A. The spectrum, at low tempera-
ture, was formed by a broad and relatively symmetric band with a
maximum at about 1644 cm−1 which would mainly correspond to a
mixture of unordered and helical structures [41]. Like with the circular
dichroism results for StAsp-PSI reported by Bryksa et al. [42], the IR
results for StAsp-PSI obtained here indicate a high degree of conforma-
tional stability of the protein in solution (Fig. 2A). However, another
band at about 1620 cm−1 appeared in the spectrum at 40 °C, which
increased in intensity as the temperature was raised. According to
previous reports [41,43], this band should correspond to aggregated
structures. These data suggest that StAsp-PSI changed from a mixture
of helical and unordered structures at low temperatures to a mixture
of helical, unordered and aggregated structures at high temperatures.
Furthermore, this transitional change in overall structure occurs at
about 45–50 °C (Fig. 2D).
In order to study any structural changes of StAsp-PSI when bounded
to phospholipid membranes, samples containing both, phospholipids
and StAsp-PSI, were prepared as described in Materials and methods.
Results obtained show that in the presence of either DMPC or DMPG,
the Amide I′ envelope of StAsp-PSI was rather similar to that found for
the protein in solution at all temperatures assayed (Fig. 2B and C,
respectively). These data would suggest that not signiﬁcant changes in
the structure of StAsp-PSI were induced by its interaction with the
membrane.
Fig. 2. Stacked infrared spectra in the C_O and Amide I′ region for StAsp-PSI in solution (A) and in the presence of DMPC (B) and DMPG (C) at different temperatures as indicated. The
phospholipid/proteinmolar ratiowas 50:1. The temperature dependence of the 1644 cm−1/1620 cm−1 intensity relationship for StAsp-PSI in solution (-) and in thepresence of DMPC (- -
-) and DMPG (-·-) are shown in panel D. See text for details.
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StAsp-PSI, we have applied several enhancementmethods, such as self-
deconvolution and derivative methods, to the original envelope as well
as decomposition of the Amide I′ infrared band [37]. Analysis of StAsp-
PSI in solution shows component bands with frequencies of 1672,
1657, 1645, 1631 and 1615 cm−1 (Fig. 3A). We have analyzed the
results obtained taking into account that the band appearing at
1672 cm−1 is due to turns, the band at 1657 cm−1 to α-helix, the
band at 1645 cm−1 to either random or α-helix or both, the band at
1631 cm−1 to β-sheet, and the band at 1615 cm−1 would correspond
to amino acid side chain vibrations [44–48]. The secondary structure
of the protein in solution and at 20 °C would consist of about 13% of
turns, 26% of α-helix, 28% of either random or α-helix or both and
33% of β-sheet (Table 1). Therefore, the results acquired here are in
agreement with previous results obtained from the circular dichroism
analysis of StAsp-PSI. These analyses showed that StAsp-PSI adopts a
similar secondary structure reported for other SAPLIPs that include a
high content of α-helix (approximately 54%) [21,29,49,50]. The same
number of bands with similar frequencies was identiﬁed for StAsp-PSI
in the presence of zwitterionic and anionic membranes. However, the
interaction of StAsp-PSI with membranes composed of either DMPC or
DMPG (Fig. 3B and C, respectively) leads to an increase of the band
intensity corresponding to either random or α-helix or both structuresfrom 28% to 35% for DMPC membranes and to 36% for DMPG mem-
branes (Table 1). As shown above, no dramatic changes in the structure
of StAsp-PSI on binding to the phospholipid membranes were detected.
3.3. Effects of StAsp-PSI on the structural and thermotropic properties of
membranes
Membrane lipids undergo a cooperative melting reaction, which is
linked to the loss of conformational order of the lipid chains and it has
been known for a long time that themelting process ofmembrane lipids
is inﬂuenced by many types of molecules including proteins and pep-
tides. The effect of StAsp-PSI on the structural and thermotropic proper-
ties of phospholipid membranes was investigated by measuring the
steady-state ﬂuorescence anisotropy of the ﬂuorescent probes DPH
and TMA-DPH incorporated into model membranes composed of satu-
rated synthetic phospholipids as a function of temperature (Fig. 4). DPH
is known to partition mainly into the hydrophobic core of the mem-
brane, whereas TMA-DPH is oriented at the membrane bilayer with its
charge localized at the lipid–water interface [36]. Their different loca-
tions and orientations in the membrane allow analyzing the effect of
StAsp-PSI on the structural and thermotropic properties along the full
length of the membrane. For DMPG and DMPS, StAsp-PSI decreased
signiﬁcantly the cooperativity of the thermal transition and in addition
Fig. 3. Amide I′ band decomposition of StAsp-PSI in solution (A) and in the presence of DMPC (B) and DMPG (C) at an original phospholipid/protein molar ratio of 50:1 in D2O buffer at
20 °C. The component bands, the envelope, and the difference between the ﬁtted curve and the original spectrum are shown.
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B, C and D). On the other hand, StAsp-PSI produced a signiﬁcant change
in the anisotropy both below and above the main transition tempera-
ture on DMPG and DMPS in the presence of both ﬂuorescent probes.
When DMPC membranes were used, StAsp-PSI did not produce any
changes in the cooperativity of the phospholipid, although a slight
shift of Tm to higher temperatures was detected. This effect was higher
for TMA-DPH than for DPH (Fig. 4E and F). These results suggest that,
StAsp-PSI is able to perturb the phospholipid acyl chains of negatively
charged phospholipids. According to already reported data [51], our
results suggest that protein incorporation into the lipid bilayer is affect-
ed by the difference in charge between the phospholipid head groups.
Therefore, StAsp-PSI should be primarily located at the lipid–water
interface inﬂuencing the ﬂuidity of the phospholipids.
3.4. Effects of StAsp-PSI on the thermotropic phase behavior of MLVs
Differential scanning calorimetry (DSC) is a powerful, non-perturbing
thermodynamic technique which has proven very useful for studies of
lipid–protein interactions in model and biological membranes in generalTable 1
Secondary structure content, in %, of StAsp-PSI in different environments as determined by FTI
Structural assignmentb % Turns
(band at ~1672 cm−1)
% α-Helix
(band at ~165
StAsp-PSI (in solution) 13c 26
StAsp-PSI + DMPC 8 26
StAsp-PSI + DMPG 11 23
a Errors in the band areas are estimated to be ±2 cm−1 (see text for details).
b There is a band centered at about 1615 cm−1, assigned to amino acid side chains, which h
c Values are rounded off to the nearest integer.and for the study of the interactions of AMPs with lipid bilayer model
membranes in particular [52–54]. We have used DSC to analyze the
effect of StAsp-PSI on the thermotropic phase behavior of the major
phospholipid classes of bacterial and animal cells. Since PCs are vir-
tually absent in bacterial membranes but are generally the most
abundant phospholipid class in eukaryotic plasma membrane, DMPC
bilayers can serve as a model for the surface membrane of the cells of
higher animals, especially as PCs are typically localized primarily in
the outer monolayer of the lipid bilayer of such membranes. On the
other hand, PGs are absent from eukaryotic plasma membranes, but
are ubiquitous and often abundant in prokaryotic surface membranes
and responsible for their negative charge [55]. The effect of StAsp-PSI
on the thermotropic phase behavior of multilamellar vesicles (MLVs)
with different compositions (DMPC, DMPG, and DMPS) is shown in
Fig. 5. Results obtained demonstrate that, in the absence of StAsp-PSI,
DMPC and DMPG exhibit two endothermic events on heating. A weak
energetic pretransition, corresponding to the melting of the lipid
headgroups, was observed at 14 °C for DMPC and 11 °C for DMPG,
and a strong energetic main phase transition near 24 and 23 °C respec-
tively, corresponding to the highly cooperative gel/liquid-crystallineR.a
7 cm−1)
% Random/α-helix
(band at ~1645 cm−1)
β-Sheet
(band at ~1631 cm−1)
28 33
35 31
36 30
as not been taken into account to determine the percentage of secondary structure.
Fig. 4. Steady-state anisotropy, brN, of DPH (A, C and E) and TMA-DPH (B, D and F) incorporated into DMPG (A and B), DMPS (C andD) andDMPC (E and F)modelmembranes as a function
of temperature. Data correspond to vesicles containing pure phospholipids (○) and phospholipids plus StAsp-PSI at a 25:1 molar ratio (●).
Fig. 5.Differential scanning calorimetry heating-scan thermograms formodelmembranes composed of DMPC (A), DMPG (B) andDMPS (C) in the absence (upper curves) and in the pres-
ence (lower curves) of StAsp-PSI at a phospholipid/protein molar ratio of 25:1. All thermograms were normalized to the same amount of phospholipid.
344 F. Muñoz et al. / Biochimica et Biophysica Acta 1838 (2014) 339–347
345F. Muñoz et al. / Biochimica et Biophysica Acta 1838 (2014) 339–347(chainmelting) transition of the lipid side chains (Fig. 5A and B). On the
other hand, DMPS exhibits a single endothermic transition at approxi-
mately 35 °C, which corresponds to the highly cooperative gel/liquid-
crystalline phase transition of the lipid (Fig. 5C). In the presence of
StAsp-PSI, the thermotropic phase behavior of DMPC was signiﬁcantly
modiﬁed, since the pretransition disappeared and the enthalpy of the
main phase transition was reduced. For both anionic phospholipids
DMPG and DMPS, the presence of StAsp-PSI signiﬁcantly broadened
the transition of the phospholipids in accordance with the anisotropy
results described above (Fig. 5B and C). Moreover, the main transition
is apparently composed of at least two different peaks, which should
be due to mixed phases (Tm of 22.2 and 35.9 °C for DMPG and 38.9
and 42.3 °C for DMPS). The coexistence of at least two phaseswould in-
dicate that one of them would be enriched in StAsp-PSI (phospholipids
highly disturbed) whereas the other one would be impoverished in it
(phospholipids slightly disturbed).
4. Discussion
Induced permeabilization of cell membranes is one of the most
common killing mechanisms produced by antimicrobial proteins
and peptides (AMPs) [56,57]. In this work we have analyzed the struc-
tural and dynamic features which might be relevant for membrane
disruption during StAsp-PSI–membrane interaction.
For several peptides, formation of multimeric pores has been sug-
gested to be responsible for membrane permeabilization [58–62]. A
peptide that forms pores, deﬁned as passageways of any kind that
have limited apertures, will lead to leakage of vesicle contents in aman-
ner that depends on the size of the solute [57]. If, however, the peptide
acts in a detergent-like manner and micellizes the membrane, there
should be no preference in the release of markers of different sizes
[57]. In this work, results obtained from leakage assays suggest that
the release of size-marker molecules from vesicles composed of
EPC/EPG is related to the StAsp-PSI concentration. Since, for large size
molecules such as FD70, a 50% of leakage was observed at a StAsp-PSI
amount 3-folds higher (8.5 μM) than the necessary StAsp-PSI amountFig. 6. Schematic overview of the possible mechanism of interaction of StAsp-PSI with membra
membranes (A, B), positively charged residues of StAsp-PSI interact weakly with the head grou
group of the negative phospholipids (3); insertion of the proteins into themembrane interface (
leading to aggregation necessary for peptide induced pore formation. In membranes composed
structure. The presenceof cholesterol in zwitterionic (B) and anionic (D)membranes prevents la
groups of zwitterionic phospholipids are colored in light gray and thehead groups of negativelyto produce the same effect when smaller ﬂuorophores (i.e., calcein and
carboxyﬂuorescein) were used (2.5 μM) [29]. Like the results previously
reported by Benachir and Laﬂeur [63], these results could indicate that
the StAsp-PSI mechanism involved in vesicle membrane disruption in-
cludes pore formation.
Prepore formation is a prerequisite for membrane insertion;
however, monomers can effectively enter into the membrane [62].
By this way, proteinmonomers insert into the bilayer and subsequently
diffuse laterally in the membrane to assemble into multimers to form
pores [64–66]. Here we show that the leakage activity of StAsp-PSI is
signiﬁcantly increased by extending the time of incubation in the leak-
age assays, even at the lowest concentration assayed. This data suggests
that vesicle membrane disruption produced by StAsp-PSI is also depen-
dent of the time of interaction between this protein and the phospholip-
id bilayers. To other AMPs this temporal delay has been related with
lateral diffusion of the monomers to assemble into aggregates [67].
However, other assays are necessary to corroborate this relationship.
The infrared spectra of the Amide I′ region of the fully hydrated
StAsp-PSI in solution at low temperatures displayed a coexistence of
α-helix and random structures; however, a broad transition with a
concomitant increase in aggregated structures occurred at about 45 °C.
On the other hand, we have attempted to analyze the possible structural
changes in StAsp-PSI induced by the interaction with membranes of
different types of phospholipids. Analysis of IR data indicates that, in
the presence of lipid vesicles containing DMPG or DMPC, StAsp-PSI
undergoes slight changes in its secondary structure. These changes
mainly consist in an increase in the content of either random or α-helix
or both structures. That kind of structural changes has been shown to
involve a highly dynamic association–dissociationmechanism for several
peptides inducing conformational changes in the peptides bound to
membranes and possible self-association [29,68]. The loss of leakage,
fusogenic and cytotoxic activities of StAsp-PSI in the presence of DTT
has been previously reported [20,23,29,42]. Additionally, we have deter-
mined the importance of intermolecular disulﬁde bonds to produce
StAsp-PSI monomer association in the presence of the phospholipid
vesicles [29]. All these results could suggest that the presence ofnes. StAsp-PSI in monomer form comes close to the membrane target (1). In zwitterionic
p of phospholipids (2). In anionic membranes (C, D), they interact strongly with the head
4); lateral diffusion in themembrane (5); and ﬁnally conformational changes of StAsp-PSI
of PG or PS (Ci), StAsp-PSI could insert deeply into the bilayer to form a barrel-stave pore
teral diffusion of StAsp-PSI in themembrane. StAsp-PSI is representedby ribbons. Thehead
charged phospholipids are colored indark gray. Cholesterol is represented byblack ellipses.
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into the membrane to produce its disruption by pore formation.
Also, we have shown that StAsp-PSI is able to affect the steady-state
ﬂuorescence anisotropy of ﬂuorescent probes located into the palisade
structure of the membrane, since the protein was able to decrease the
mobility and transition cooperativity of the phospholipid acyl chains
of anionic membranes composed of DMPG and DMPS when compared
to the pure phospholipids. No changes were observed in the structure
of zwitterionic membranes in the presence of StAsp-PSI. Interestingly,
these data suggest that the insertion of StAsp-PSI into the bilayer pali-
sade depends on phospholipid composition.
Calorimetry experiments further corroborated these results, and
additionally indicated that StAsp-PSI induced the presence of mixed
lipid phases, enriched or impoverished in protein. This result strengthens
that the location of StAsp-PSI is at or near the membrane interface,
inﬂuencing the ﬂuidity of the phospholipids. It has also been described,
for other proteins and peptides, that an increase in gel phase disorder
and a decrease in the gel to liquid phase transition cooperativity are
related to the insertion of the protein into the membrane and thus the
spreading of the phosphate groups [69–72]. Additionally, StAsp-PSI
could insert deeply into the bilayer to form a barrel-stave pore structure
in membranes composed of DMPG and DMPS, since StAsp-PSI was able
to perturb the phospholipid acyl chains in membranes with these
compositions.
Nowadays, the interest on the study of antimicrobial peptides and
proteins has increased because of the microbial resistance developed
toward many antimicrobial compounds [73–75]. Many of these antimi-
crobial peptides not only perturb and disruptmicrobial cell membranes,
but they are also lytic to eukaryotic ones. The understanding of their
mechanism of action is therefore essential to provide a basis for the
design of peptides with a directed action toward speciﬁc cell types.
The results obtained here can be related to the selective cytotoxic
activity of StAPs and StAsp-PSI, since they interact differently with dis-
tinct types of cells because of differences in phospholipid membrane
composition [20,23,24,29].
Deﬁnitive demonstration of the mode of peptide disruption of a
bilayer is difﬁcult for an experiment model, especially as a single pep-
tide may exhibit more than one mode of interaction with the bilayer
[76]. Nevertheless, the results we have discussed here complement
other studies thatwe have done previously on StAsp-PSI [20,29]. Taking
this into account, in Fig. 6we propose amodel of interaction of StAsp-PSI
with phospholipid membranes of different compositions. In this model
we suggest that StAsp-PSI interacts in a complex, conformationally
dependent, way with phospholipid membranes, involving a number of
processes, being theﬁrst one an electrostatic interactionwith negatively
charged phospholipids, then insertion of the proteins into the mem-
brane interface, lateral diffusion in the membrane and ﬁnally aggrega-
tion, leading to the disruption of the membrane by a pore formation.
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